How strontium ranelate, via opposite effects on bone resorption and formation, prevents Osteoporosis

Osteoporosis International

Volumn 22, Issue 6, 2011, Pages 1659-1667

  Marie, P J ^a,b,e   Felsenberg, D ^c   Brandi, M L ^d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF FLORENCE   (Italy)

^e HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Bone cells; Osteoporosis; Strontium ranelate

Indexed keywords

CALCIUM SENSING RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; STRONTIUM RANELATE;

BONE DENSITY; BONE MASS; BONE STRENGTH; BONE STRUCTURE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG MECHANISM; FRACTURE; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; BONE RESORPTION; FEMALE; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; THIOPHENES;

EID: 79959993170     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1369-0     Document Type: Conference Paper

References (62)

1. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115(12):3318-3325 (Pubitemid 43121814)
2. Hauselmann HJ, Rizzoli R (2003) A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 14(1):2-12 (Pubitemid 36267895)
3. Seeman E (2003) Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14(Suppl 3):S2-S8
4. Marie PJ (2006) Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Curr Opin Rheumatol 18(suppl 1):S11-S15 (Pubitemid 44289184)
5. Baron R, Tsouderos Y (2002) In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450(1):11-17
6. Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42(1):129-138 (Pubitemid 350297175)
7. Takahashi N, Sasaki T, Tsouderos Y, Suda T (2003) S12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18(6):1082-1087 (Pubitemid 37294946)
8. Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S et al (2009) The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. J Biol Chem 284(1):575-584
9. Caverzasio J (2008) Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms. Bone 42(6):1131-1136
10. Fromigue O, Hay E, Barbara A, Petrel C, Traiffort E, Ruat M et al (2009) Calcium sensing receptor-dependent and-independent activation of osteoblast replication and survival by strontium ranelate. J Cell Mol Med 13(8 B):2189-2199
11. Fromigue O, Hay E, Barbara A, Marie PJ (2010) Essential role of nuclear factor of activated T cells (NFAT)-mediated WNT signalling in osteoblast differentiation induced by strontium ranelate. J Biol Chem 285:25251-25258
12. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18(6):517-523 (Pubitemid 26257871)
13. Chattopadhyay N, Quinn SJ, Kifor O, Ye C, Brown EM (2007) The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol 74(3):438-447 (Pubitemid 46970843)
14. Atkins GJ, Welldon KJ, Halbout P, Findlay DM (2009) Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporos Int 20(4):653-664
15. Brennan TC, Rybchyn MS, Green W, Atwa S, Conigrave AD, Mason RS (2009) Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol 157(7):1291-1300
16. Barbara A, Delannoy P, Denis BG, Marie PJ (2004) Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism 53(4):532-537 (Pubitemid 38419200)
17. Choudhary S, Halbout P, Alander C, Raisz L, Pilbeam C (2007) Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins. J Bone Miner Res 22(7):1002-1010 (Pubitemid 351339722)
18. Zhu LL, Zaidi S, Peng Y, Zhou H, Moonga BS, Blesius A et al (2007) Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun 355(2):307-311 (Pubitemid 46282628)
19. Caudrillier A, Hurtel-Lemaire AS, Wattel A, Cournarie F, Godin C, Petit L et al. (2010) Strontium ranelate decreases RANKL-induced osteoclastic differentiation in vitro: involvement of the calcium sensing receptor. Mol Pharmacol (in press)
20. Brown EM, Lian JB (2008) New insights in bone biology: unmasking skeletal effects of the extracellular calcium-sensing receptor. Sci Signal 1(35):e40
21. Chang W, Tu C, Chen TH, Komuves L, Oda Y, Pratt SA et al (1999) Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140(12):5883-5893 (Pubitemid 30645377)
22. Chang W, Tu C, Chen TH, Bikle D, Shoback D (2008) The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1(35):ra1
23. Brown EM (2003) Is the calcium receptor a molecular target for the actions of strontium on bone? Osteoporos Int 14(Suppl 3):S25-S34
24. Coulombe J, Faure H, Robin B, Ruat M (2004) In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. Biochem Biophys Res Commun 323(4):1184-1190 (Pubitemid 39296549)
25. Zhang D, Pan L, Yang LH, He XK, Huang XY, Sun FZ (2005) Strontium promotes calcium oscillations in mouse meiotic oocytes and early embryos through InsP3 receptors, and requires activation of phospholipase and the synergistic action of InsP3. Hum Reprod 20(11):3053-3061 (Pubitemid 41662655)
26. Sienaert I, Missiaen L, De SH, Parys JB, Sipma H, Casteels R (1997) Molecular and functional evidence for multiple Ca2+-binding domains in the type 1 inositol 1, 4, 5-trisphosphate receptor. J Biol Chem 272(41):25899-25906 (Pubitemid 27438915)
27. Mentaverri R, Yano S, Chattopadhyay N, Petit L, Kifor O, Kamel S et al (2006) The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 20(14):2562-2564
28. Pi M, Quarles LD (2004) A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. J Bone Miner Res 19(5):862-869 (Pubitemid 41094398)
29. Delannoy P, Bazot D, Marie PJ (2002) Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 51(7):906-911 (Pubitemid 34784820)
30. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A (2001) Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 29(2):176-179 (Pubitemid 32734498)
31. Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P et al (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8(5):607-615 (Pubitemid 23127921)
32. Bain SD, Jerome C, Shen V, Dupin-Roger I, Ammann P (2009) Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporos Int 20(8):1417-1428
33. Hott M, Deloffre P, Tsouderos Y, Marie PJ (2003) S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 33(1):115-123 (Pubitemid 36952693)
34. Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R (2004) Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 19(12):2012-2020 (Pubitemid 41103416)
35. Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22(9):1419-1425 (Pubitemid 351339686)
36. Geoffroy V, Chappard D, Marty C, Libouban H, Ostertag A, Lalande A et al. (2010) Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture. Osteoporos Int (in press)
37. Maimoun L, Brennan TC, Badoud I, Dubois-Ferriere V, Rizzoli R, Ammann P (2010) Strontium ranelate improves implant osseointegration. Bone 46(5):1436-1441
38. Li Y, Feng G, Gao Y, Luo E, Liu X, Hu J (2009) Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. J Orthop Res 28:578-582
39. Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A (2010) Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 86(1):82-89
40. Li YF, Luo E, Feng G, Zhu SS, Li JH, Hu J (2009) Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int (in press)
41. Peng S, Liu XS, Wang T, Li Z, Zhou G, Luk KD et al (2010) In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells. J Orthop Res 28:1208-1214
42. Fuchs RK, Allen MR, Condon KW, Reinwald S, Miller LM, McClenathan D et al (2008) Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int 19(9):1331-1341
43. Marie PJ (2008) Effective doses for strontium ranelate. Osteoporos Int Reply 19(12):1815-1817
44. Boivin G, Deloffre P, Perrat B, Panczer G, Boudeulle M, Mauras Y et al (1996) Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S12911) administration. J Bone Miner Res 11(9):1302-1311 (Pubitemid 26282531)
45. Li C, Paris O, Siegel S, Roschger P, Paschalis EP, Klaushofer K et al (2010) Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. J Bone Miner Res 25(5):968-975
46. Roschger P, Manjubala I, Zoeger N, Meirer F, Simon R, Li C et al (2010) Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment. J Bone Miner Res 25(4):891-900
47. Meunier PJ, Roux C, Seemar E, Ortolani S, Badurski JE, Spector TM et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350(5):459-468 (Pubitemid 38133766)
48. Reginster JY, Seeman E, De Vernejoul C, Adami S, Compston J, Phenekos C et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90(5):2816-2822 (Pubitemid 40686329)
49. Meunier PJ, Roux C, Ortolani S, az-Curiel M, Compston J, Marquis P et al (2009) Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 20(10):1663-1673
50. Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML et al (2008) Effects of long-term strontium ranelate treatment on the risk of non-vertebral and vertebral fractures in postmenopausal osteoporosis: results of a 5-year, randomized, placebo-controlled trial. Arthritis Rheum 58:1687-1695 (Pubitemid 351847521)
51. Reginster JY, Bruyere O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A et al (2009) Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Bone 45(6):1059-1064
52. Seeman E, Boonen S, Borgstrom F, Vellas B, Aquino JP, Semler J et al (2010) Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. Bone 46(4):1038-1042
53. Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z et al (2006) Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 21(4):536-542
54. Recker RR, Marin F, Ish-Shalom S, Moricke R, Hawkins F, Kapetanos G et al (2009) Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res 24(8):1358-1368
55. Bruyere O, Collette J, Reginster JY (2010) The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density: reply to Stepan et al. Osteoporos Int 0:1-2
56. Meunier PJ (2004) Postmenopausal osteoporosis and strontium ranelate-reply. N Engl J Med 350(19):2002-2003
57. Bruyere O, Collette J, Rizzoli R, Decock C, Ortolani S, Cormier C et al (2010) Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years. Osteoporos Int 21(6):1031-1036
58. Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P et al (2007) Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 92(8):3076-3081 (Pubitemid 47236373)
59. Bruyere O, Roux C, Badurski J, Isaia G, De Vernejoul MC, Cannata J et al (2007) Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr Med Res Opin 23(12):3041-3045
60. Kendler DL, Adachi JD, Josse RG, Slosman DO (2009) Monitoring strontium ranelate therapy in patients with osteoporosis. Osteoporos Int 20(7):1101-1106
61. Arlot ME, Jiang Y, Genant HK, Zhao J, Burt-Pichat B, Roux JP et al (2008) Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res 23(2):215-222 (Pubitemid 351160035)
62. Rizzoli R, Laroche M, Krieg MA, Frieling I, Thomas T, Delmas P et al (2010) Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis. Rheumatol Int 30:1341-1348